The FDA’s Ties To The Gates Foundation

HNewsWire: by Tyler Durden Authored by Maryanne Demasi via The Brownstone Institute, In 2017, the US Food and Drug Administration (FDA) entered into a memorandum of understanding (MOU) with the Bill & Melinda Gates Foundation. Under the MOU, the two entities agreed to share information to “facilitate the development of innovative products, including medical countermeasures,” such as diagnostics, vaccines, and therapeutics to combat disease transmission during a pandemic. The FDA has MOUs with many academic and non-profit organisations, but few have as much to gain as Bill Gates, who has invested billions into pandemic countermeasures. Experts are concerned the Gates Foundation could have undue influence over the FDA’s regulatory decisions of these countermeasures. David Gortler, an ex-senior adviser to the FDA commissioner between 2019 and 2021, says he is “suspicious” of the MOU. “If the Gates Foundation establishes an MOU with a regulator on a…

Read More

One Honest Judge Rejects FDA’s 75 Year Delay on Vax Data, Cuts to Just 8 Months

Newsletter Name Please enter your name. Email Address Please enter a valid email address. Subscribe! Thanks for subscribing! Please check your email for further instructions. Something went wrong. Please check your entries and try again. Support Orphans Support The 127.org One Orphan’s Story Editor’s Bio A Thrilling Ride! Every once in awhile, a book comes across your path that is impossible to put down. A Long Journey Home is not a casual book that you read in a week or earmark to complete at a later date. Once you begin, cancel your schedule, put your phone on silent, find a quiet place where you cannot be disturbed, and complete the journey. Click Here to Purchase on Amazon.com! Reach People Reach 250K / Month Mr Gain Of Function cracks me up. Pushes kill jabs like a drug dealer, knows the kill jabs…

Read More

FDA Advisors Plead Against Additional Boosters. We’ll See If They’re Heard This Time.

During a meeting on April 6 where FDA officials said they aim to decide on the future vaccination strategy by June, experts who advise the US Food and Drug Administration (FDA) spoke out against a strategy of multiple COVID-19 vaccine boosts in a short period of time. During a virtual meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee, Dr. Amanda Cohn, a CDC official, said, “I do not feel that booster every eight weeks or even four months is a long-term approach for prevention.” Dr. Arnold Monto, the committee’s interim chair, later remarked, “We don’t feel comfortable with several boosters every eight weeks.” “An annual vaccination, similar to influenza, would be fantastic.” The FDA approved a second booster of the Pfizer and Moderna COVID-19 vaccinations for all Americans 50 and older, as well as individuals as young…

Read More